CaleeTech

CaleeTechCaleeTech
CaleeTech

CaleeTech

Biotech startup developing novel oral formulations for obesity and diabetes.

DR 3.52019Active13Tel Aviv, Israel
Rate

About

CaleeTech is a clinical-stage biotech startup specializing in novel solutions for obesity and diabetes. The company develops unique, transient, and repeatedly usable products designed to improve glycemic control and weight loss by reducing calorie, blood sugar, and fat levels without compromising patient quality of life. Their products are based on FDA-approved ingredients, are easy to use, and have undergone extensive clinical and in-vivo testing.
Frequently asked

What does CaleeTech do?

CaleeTech is a clinical-stage biotech startup specializing in novel solutions for obesity and diabetes. The company develops unique, transient, and repeatedly usable products designed to improve glycemic control and weight loss by reducing calorie, blood sugar, and fat levels without compromising patient quality of life. Their products are based on FDA-approved ingredients, are easy to use, and have undergone extensive clinical and in-vivo testing. (formerly Obvislim.)

What is CaleeTech's revenue?

StartupHub estimates CaleeTech's annual revenue at $2.8M (range $2.1M to $5.7M, 64% confidence), based on comparable companies in the sector.

Where is CaleeTech headquartered?

CaleeTech is headquartered in Tel Aviv, Israel.

When was CaleeTech founded?

CaleeTech was founded in 2019.

What industry does CaleeTech operate in?

CaleeTech operates in Healthcare, Diabetes, Glucose, Biotech, HealthTech, Drug Discovery.

How many employees does CaleeTech have?

CaleeTech has approximately 13 people on record.

HEADCOUNT
13
DOMAIN RATING
3.5
Comments

No comments yet. Be the first to share your take.